Skip to main content
. 2022 Feb 21;35(3):275–280. doi: 10.20524/aog.2022.0699

Table 2.

Patient characteristics while on vedolizumab, stratified by BMI <30 kg/m2 or ≥30 kg/m2

graphic file with name AnnGastroenterol-35-275-g002.jpg